Market Overview

Next Generation Sequencing for Non-invasive Prenatal Testing - Global Insights Report 2017-2018 & 2023 - ResearchAndMarkets.com

Share:

The "Next
Generation Sequencing for Non-invasive Prenatal Testing: Global Insights"

report has been added to ResearchAndMarkets.com's
offering.

The scope of the report includes NIPT methods, applications, patents and
companies. The markets for NGS-based NIPT are given for the years 2017,
2018 and 2023.

This report reviews the main sequencing technologies and provides
detailed discussion on next generation sequencing and its applications
in different fields. The main focus of the study is NIPT. The market
dynamics such as drivers and restraints for both NGS and NIPT market
have been discussed in this report.

The report examines the markets by NIPT methods, high-risk and low-risk
pregnancies and geography. The end-user segment of this market is based
on disease area and healthcare setting. Disease areas include trisomies
21, 18 and 13 and Turner syndrome (a sex chromosome aneuploidy).
Healthcare settings include diagnostic laboratories and hospitals.

As a background study, industry sectors analyzed include sequencing
instruments, target enrichment, informatics, clinical laboratory testing
services, reproductive health diagnostics, liquid biopsy, immune
sequencing, HLA typing, third generation sequencing and direct to
consumer.

This research provides a summary of the main industry acquisitions and
strategic alliances from 2016 through April 2018, including key alliance
trends.

Comprehensive profiles of the leading companies involved in the
clinical, genetic testing and sequencing industries, including 10X
Genomics, Inc., 23andMe, Agilent Technologies, Inc., Illumina Inc. and
Natera, Inc

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Summary And Highlights

Chapter 3 Next Generation Sequencing Overview

Chapter 4 Next Generation Sequencing Applications

Chapter 5 Next Generation Sequencing Based Non-Invasive Prenatal Testing

Chapter 6 Market Breakdown By Nipt Methods

Chapter 7 Ngs-Nipt End Users

Chapter 8 Market Breakdown By Region

Chapter 9 Patent Review

Chapter 10 Analysis Of Market Opportunities

Chapter 11 Competitive Landscape

Chapter 12 Company Profiles

  • 10X Genomics
  • 23Andme
  • Agilent Technologies, Inc.
  • Annoroad
  • Berry Genomics
  • BGI (Beijing Genomics Institute)
  • Eurofin Gatc - Lifecodexx Ag
  • Eurofins Gatc Biotech
  • Illumina Inc.
  • Knome, Inc. / Tute Genomics / Pierian Dx
  • Labcorp
  • Labcorp-Sequenom Laboratories
  • Natera, Inc.
  • Nipd Genetics
  • Oxford Nanopore Technologies Ltd.
  • Pacific Biosciences Of California
  • Perkinelmer, Inc.
  • Pieriandx, Inc.
  • Premaitha Health Plc
  • Qiagen Nv
  • Roche Holding Ag
  • Thermo Fisher Scientific Inc.

For more information about this report visit https://www.researchandmarkets.com/research/zjp9bv/next_generation?w=4

View Comments and Join the Discussion!